Obiettivo
Partners come from 10 European countries to achieve two main objectives: A) The further exploration of 3 animal models (the OBX rat, GS rat and NOD mouse) characterized by an activated immune response system (IRS), an abnormal tryptophan catabolism and a depressive-like behaviour to study the pathogenesis of inflammation-related mood disorders and the efficacy/working mechanism of anti-inflammatory and tryptophan metabolism restoring drugs. B) The in-parallel study of mood disorder patients to validate two sets of already developed biomarker tests to identify patients and individuals at risk for a mood disorder and characterized by an activated IRS to be able to treat these patients/individuals with drugs counteracting the consequences of the activated IRS/disturbed catabolism of tryptophan. Five strategic approaches (broken down in 12 workpackages) are used: 1) Study of the animal models for depressive-like behavior and aberrancies in monocytes/ macrophages, the tryptophan metabolism and the microglia-astrocyte-neuron interaction. 2/3) The validation of a high-throughput biomarker mRNA blood monocyte signature test and a biomarker test to detect an abnormal tryptophan catabolism. 4) Correlation studies between the outcomes of these biomarker tests in patients to various clinical variables, a.o. gene polymorphisms and the brain scan. 5) The therapeutic targetting of the activated IRS/abnormal tryptophan catabolism using a PDE4 inhibitor, a COX-2 inhibitor and a KMO-inhibitor in the animal models and in a phase II intervention study in depressed patients. Novel approaches are the prospective assessment of patients/individuals to identify whether changes in the IRS have any prognostic value and that the program aims at a personalized treatment of patients on the basis of their activated IRS. We heavily rely in this on the study of the animal models, which allow us to test anti-inflammatory therapeutics and to know their mechanism of action at the brain.
Campo scientifico
Parole chiave
Argomento(i)
Invito a presentare proposte
FP7-HEALTH-2007-B
Vedi altri progetti per questo bando
Meccanismo di finanziamento
CP-IP - Large-scale integrating projectCoordinatore
3015 GD Rotterdam
Paesi Bassi
Mostra sulla mappa
Partecipanti (20)
80539 MUNCHEN
Mostra sulla mappa
48149 MUENSTER
Mostra sulla mappa
9713 GZ Groningen
Mostra sulla mappa
6020 Innsbruck
Mostra sulla mappa
3000 Leuven
Mostra sulla mappa
WC2R 2LS London
Mostra sulla mappa
20132 MILANO
Mostra sulla mappa
1463 Sofia
Mostra sulla mappa
D02 CX56 Dublin
Mostra sulla mappa
BD7 1DP Bradford
Mostra sulla mappa
75654 Paris
Mostra sulla mappa
20100 Rozzano (Mi)
Mostra sulla mappa
751 05 Uppsala
Mostra sulla mappa
Partecipazione conclusa
3051 HM ROTTERDAM
Mostra sulla mappa
2300 Turnhout
Mostra sulla mappa
82152 Martinsried
Mostra sulla mappa
20091 BRESSO
Mostra sulla mappa
79106 Freiburg
Mostra sulla mappa
3584 CX Utrecht
Mostra sulla mappa
20132 Milano
Mostra sulla mappa